share_log

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session

周二盘后交易时段，12只医疗保健股走势
Benzinga Real-time News ·  2023/01/03 16:31

Gainers

获胜者

  • Novo Integrated Sciences (NASDAQ:NVOS) stock rose 8.3% to $0.2 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 4.7 million shares, which is 1896.1 percent of its average volume over the last 100 days. The company's market cap stands at $6.9 million.
  • eFFECTOR Therapeutics (NASDAQ:EFTR) shares increased by 8.13% to $0.5. The market value of their outstanding shares is at $20.9 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) stock moved upwards by 7.79% to $0.7. Trading volume for this security closed at 68.5K, accounting for 2.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.0 million.
  • Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 4.99% to $0.84. This security traded at a volume of 79.1K shares come close, making up 7.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $5.3 million.
  • Agile Therapeutics (NASDAQ:AGRX) shares increased by 4.98% to $0.23. The company's market cap stands at $9.2 million.
  • Mersana Therapeutics (NASDAQ:MRSN) stock moved upwards by 4.88% to $6.01. The market value of their outstanding shares is at $599.6 million.
  • Novo 综合科学 纳斯达克股票代码：NVOS）股价在周二的盘后交易时段上涨8.3％，至0.2美元。该证券今天的交易量最终收于470万股，占其过去100天平均交易量的1896.1％。该公司的市值为690万美元。
  • Effector 疗法 纳斯达克股票代码：EFTR）的股价上涨了8.13％，至0.5美元。他们已发行股票的市值为2,090万美元。
  • TransCode 治疗学 纳斯达克股票代码：RNAZ）的股票上涨了7.79％，至0.7美元。该证券的交易量收于68.5万，占其过去100天平均全日交易量的2.1％。他们已发行股票的市值为900万美元。
  • 恩赛斯生物科学 纳斯达克股票代码：ENSC）的股票上涨了4.99％，至0.84美元。该证券的交易量接近79.1万股，占其过去100天平均交易量的7.2％。他们已发行股票的市值为530万美元。
  • 敏捷疗法 纳斯达克股票代码：AGRX）的股价上涨了4.98％，至0.23美元。该公司的市值为920万美元。
  • 梅尔萨纳疗法 纳斯达克股票代码：MRSN）的股票上涨了4.88％，至6.01美元。他们已发行股票的市值为5.996亿美元。

Losers

失败者

  • Vera Therapeutics (NASDAQ:VERA) stock declined by 62.9% to $6.8 during Tuesday's after-market session. Trading volume for this security closed at 734.5K, accounting for 559.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $188.0 million.
  • Gelesis Holdings (NYSE:GLS) stock fell 21.16% to $0.41. Gelesis Holdings's trading volume hit 132.1K shares by close, accounting for 96.8% of its average volume over the last 100 days. The company's market cap stands at $29.9 million.
  • Apyx Medical (NASDAQ:APYX) shares declined by 8.34% to $2.31. The company's market cap stands at $79.9 million.
  • Baudax Bio (NASDAQ:BXRX) shares fell 7.81% to $3.19. This security traded at a volume of 65.8K shares come close, making up 5.7% of its average volume over the last 100 days. The company's market cap stands at $1.7 million.
  • NexGel (NASDAQ:NXGL) stock declined by 6.77% to $1.24. The company's market cap stands at $6.9 million.
  • Lucira Health (NASDAQ:LHDX) shares decreased by 6.67% to $0.56. This security traded at a volume of 2.2 million shares come close, making up 665.4% of its average volume over the last 100 days. The company's market cap stands at $22.7 million. See Also:
  • 维拉疗法 纳斯达克股票代码：VERA）股价在周二的盘后交易时段下跌了62.9％，至6.8美元。该证券的交易量收于734.5K，占其过去100天平均全日交易量的559.2％。他们已发行股票的市值为1.88亿美元。
  • 吉莱西斯控股公司 纽约证券交易所代码：GLS）股价下跌21.16％，至0.41美元。Gelesis Holdings的交易量收盘时达到132.1万股，占其过去100天平均交易量的96.8％。该公司的市值为2990万美元。
  • Apyx Medical 纳斯达克股票代码：APYX）股价下跌8.34％，至2.31美元。该公司的市值为7,990万美元。
  • Baudax Bio 纳斯达克股票代码：BXRX）股价下跌7.81％，至3.19美元。该证券的交易量接近65.8万股，占其过去100天平均交易量的5.7％。该公司的市值为170万美元。
  • NexGel 纳斯达克股票代码：NXGL）股价下跌6.77％，至1.24美元。该公司的市值为690万美元。
  • 露西拉健康 纳斯达克股票代码：LHDX）股价下跌6.67％，至0.56美元。该证券的交易量接近220万股，占其过去100天平均交易量的665.4％。该公司的市值为2270万美元。 另请参阅：

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成，并由编辑审阅。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发